+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-01-06Number of Pages: 178

Psoriasis Treatment Market (Product - TNF Inhibitors, Vitamin D Analogues or Combinations, and Interleukin Blockers; Therapy - Topical Therapeutic Drugs, Systemic Therapeutic Drugs, and Combinations; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Psoriasis Treatment Market: Snapshot

The alarming rise in the number of psoriasis patients is having the most prominent impact on the global market for psoriasis treatment. With the increasing FDA approval for novel drugs and therapies for psoriasis treatment, the market is likely to surge remarkably over the next few years. Apart from this, the presence of a strong product pipeline and the growing awareness regarding psoriasis and its treatment among people in emerging economies are also projected to propel this market in the near future.

According to Transparency Market Research (TMR), the global market for psoriasis treatment offered an opportunity worth US$7.8 bn in 2015. Researchers estimate this market to rise at a CAGR of 5.10% between 2016 and 2024 and reach US$12.1 bn by 2024.

psoriasis treatment market

TNF Inhibitors Report Higher Demand

TNF Inhibitors, interleukin blockers, and vitamin D analogues or combination have emerged as the key products available in the worldwide market for psoriasis treatment. Driven by superior efficiency and safety, TNF inhibitors are reporting a higher demand than other products in this market. By 2024, the segment is expected to remain on top with an estimated share of more than 47% in the overall market. However, the introduction of biosimilars may limit this demand to some extent in the years to come.

Interleukin blockers, on the flip side, is projected to present a lucrative growth opportunity to market players over the coming years due to their augmenting usage and their ability to act selectively by targeting the proteins.

Increasing Pool of Psoriasis Patients to Ensure North America’s Dominance

On the basis of geography, Latin America, North America, Europe, Middle East and Africa, and Asia Pacific are considered as the prime regional market for psoriasis treatment. North America has surfaced as the key contributor to this market and is likely to retain this position in the near future. The remarkable rise in the patient pool suffering from psoriasis is projected to boost this regional market over the coming years. The presence of well-established drugmakers is also expected to have positive influence on the North America market for psoriasis treatment in the years to come.

Europe, although currently having a strong position in the overall market, is likely to experience a decline in the demand psoriasis treatment, following an intense competition from biosimilars over the next few years. Latin America and Asia Pacific, on the other hand, are anticipated to witness a significant rise in their respective markets over the next few years. The increasing awareness regarding psoriasis and its treatment among people in emerging economies, such as China and India, through various government and NGO campaigns is projected to stimulate the Asia Pacific market for psoriasis treatment considerably in the near future.

Biogen, LEO Pharma A/S, AbbVie Inc., AstraZeneca, Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Eli Lilly & Co., and Amgen Inc. are some of the prominent players in the global market for psoriasis treatment.

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions     
     2.2. Research Methodology

3. Executive Summary
     3.1. Global Psoriasis Treatment Market Snapshot
     3.2. Market Share Analysis by Region, 2015
     3.3. Global Psoriasis Treatment Market : Opportunity Map

4. Market Overview
     4.1. Product Overview
     4.2. Global Psoriasis Treatment Market : Key Industry Events
     4.3. Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014–2024
     4.4. Psoriasis Treatment Market Outlook
     4.5. Global Psoriasis Treatment Supply Demand Scenario 
     4.6. Porter’s Analysis 

5. Market Dynamics
     5.1. Drivers
           5.1.1. Approval of new biologics
           5.1.2. Increase in access for treatment in developing markets 
           5.1.3. Novel Pipeline Drugs
           5.1.4. Increase in the number of psoriasis patients
     5.2. Restrains
           5.2.1. Loss of response to current therapies
           5.2.2. Premium-priced biologics
     5.3. Opportunities
           5.3.1. Newer modalities and availability of predictive biomarkers, offer opportunity of personalized treatment for psoriasis
           5.3.2. Specialty biologics set to lose their exclusivity status
     5.4. Key Trends
           5.4.1. Increasing cost of psoriasis biologics
           5.4.2. The number of physicians that practice independently has been declining

6. Psoriasis Treatment Market Analysis, by Product Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Psoriasis Treatment Market Value Share Analysis, by Product Type
     6.4. Psoriasis Treatment Market Analysis, by Product Type 
           6.4.1. TNF Inhibitors
           6.4.2. Vitamin D Analogues or Combinations
           6.4.3. Interleukin Blockers
           6.4.4. Others
     6.5. Psoriasis Treatment Market Attractiveness Analysis, by Product Type 
     6.6. Key Trends

7. Psoriasis Treatment Market Analysis, by Therapy
     7.1. Key Findings
     7.2. Introduction
     7.3. Global Psoriasis Treatment Market Value Share Analysis, by Therapy
     7.4. Psoriasis Treatment Market Analysis, by Therapy
           7.4.1. Topical Therapeutic Drugs
           7.4.2. Systemic Therapeutic Drugs
           7.4.3. Combinations & Others
     7.5. Psoriasis Treatment Market Attractiveness Analysis, by Therapy
     7.6. Key Trends

8. Psoriasis Treatment Market Analysis, by Distribution Channel
     8.1. Key Findings
     8.2. Introduction
     8.3. Global Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     8.4. Psoriasis Treatment Market Analysis, by Distribution Channel
           8.4.1. Hospital Pharmacy
           8.4.2. Retail Pharmacy
           8.4.3. Online Sales
     8.5. Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
     8.6. Key Trends

9. Psoriasis Treatment Market Analysis, by Region
     9.1. Global Psoriasis Treatment Market Snapshot, by Country
     9.2. Global Psoriasis Treatment Market Value Share Analysis, by Region
     9.3. Psoriasis Treatment Market Forecast, by Region
     9.4. Psoriasis Treatment Market Attractiveness Analysis, by Region

10. North America Psoriasis Treatment Market Analysis
     10.1. Key Findings
     10.2. North America Psoriasis Treatment Market Overview
     10.3. North America Market Value Share Analysis, by Product
     10.4. North America Market Forecast, by Product
           10.4.1. TNF Inhibitors
           10.4.2. Vitamin D Analogues or Combinations
           10.4.3. Interleukin Blockers
           10.4.4. Others
     10.5. North America Market Value Share Analysis, by Therapy
     10.6. North America Market Forecast, by Therapy
           10.6.1. Topical Therapeutic Drugs
           10.6.2. Systemic Therapeutic Drugs
           10.6.3. Combinations & Others 
     10.7. North America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     10.8. North America Market Forecast, by Distribution Channel
           10.8.1. Hospital Pharmacy
           10.8.2. Retail Pharmacy
           10.8.3. Online Sales 
     10.9. Market Analysis, by Country
     10.10. Market Value Share Analysis, by Country
     10.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           10.11.1. U.S.
           10.11.2. Canada
     10.12. Market Attractiveness Analysis
           10.12.1. By Product
           10.12.2. By Therapy
           10.12.3. By Distribution Channel
           10.12.4. By Country
     10.13. Market Trends

11. Europe Psoriasis Treatment Market Analysis
     11.1. Key Findings
     11.2. Europe Psoriasis Treatment Market Overview
     11.3. Europe Market Value Share Analysis, by Product
     11.4. Europe Market Forecast, by Product
           11.4.1. TNF Inhibitors
           11.4.2. Vitamin D Analogues or Combinations
           11.4.3. Interleukin Blockers
           11.4.4. Others
     11.5. Europe Market Value Share Analysis, by Therapy
     11.6. Europe Market Forecast, by Therapy
           11.6.1. Topical Therapeutic Drugs
           11.6.2. Systemic Therapeutic Drugs
           11.6.3. Combinations & Others 
     11.7. Europe Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     11.8. Europe Market Forecast, by Distribution Channel
           11.8.1. Hospital Pharmacy
           11.8.2. Retail Pharmacy
           11.8.3. Online Sales 
     11.9. Market Analysis, by Country
     11.10. Market Value Share Analysis, by Country
     11.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           11.11.1. Germany
           11.11.2. U.K.
           11.11.3. Spain
           11.11.4. Italy
           11.11.5. France
           11.11.6. Rest of Europe
     11.12. Market Attractiveness Analysis
           11.12.1. By Product
           11.12.2. By Therapy
           11.12.3. By Distribution Channel
           11.12.4. By Country
     11.13. Market Trends

12. Asia Pacific Psoriasis Treatment Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Psoriasis Treatment Market Overview
     12.3. Asia Pacific Market Value Share Analysis, by Product
     12.4. Asia Pacific Market Forecast, by Product
           12.4.1. TNF Inhibitors
           12.4.2. Vitamin D Analogues or Combinations
           12.4.3. Interleukin Blockers
           12.4.4. Others
     12.5. Asia Pacific Market Value Share Analysis, by Therapy
     12.6. Asia Pacific Market Forecast, by Therapy
           12.6.1. Topical Therapeutic Drugs
           12.6.2. Systemic Therapeutic Drugs
           12.6.3. Combinations & Others 
     12.7. Asia Pacific Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     12.8. Asia Pacific Market Forecast, by Distribution Channel
           12.8.1. Hospital Pharmacy
           12.8.2. Retail Pharmacy
           12.8.3. Online Sales 
     12.9. Market Analysis, by Country
     12.10. Market Value Share Analysis, by Country
     12.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           12.11.1. Japan
           12.11.2. China
           12.11.3. Australia & New Zealand
           12.11.4. India
           12.11.5. Rest of Asia Pacific
     12.12. Market Attractiveness Analysis
           12.12.1. By Product
           12.12.2. By Therapy
           12.12.3. By Distribution Channel
           12.12.4. By Country
     12.13. Market Trends

13. Latin America Psoriasis Treatment Market Analysis
     13.1. Key Findings
     13.2. Latin America Psoriasis Treatment Market Overview
     13.3. Latin America Market Value Share Analysis, by Product
     13.4. Latin America Market Forecast, by Product
           13.4.1. TNF Inhibitors
           13.4.2. Vitamin D Analogues or Combinations
           13.4.3. Interleukin Blockers
           13.4.4. Others
     13.5. Latin America Market Value Share Analysis, by Therapy
     13.6. Latin America Market Forecast, by Therapy
           13.6.1. Topical Therapeutic Drugs
           13.6.2. Systemic Therapeutic Drugs
           13.6.3. Combinations & Others 
     13.7. Latin America Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     13.8. Latin America Market Forecast, by Distribution Channel
           13.8.1. Hospital Pharmacy
           13.8.2. Retail Pharmacy
           13.8.3. Online Sales 
     13.9. Market Analysis, by Country
     13.10. Market Value Share Analysis, by Country
     13.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           13.11.1. Brazil
           13.11.2. Mexico
           13.11.3. Rest of Latin America
     13.12. Market Attractiveness Analysis
           13.12.1. By Product
           13.12.2. By Therapy
           13.12.3. By Distribution Channel
           13.12.4. By Country
     13.13. Market Trends

14. Middle East & Africa Psoriasis Treatment Market Analysis
     14.1. Key Findings
     14.2. Middle East & Africa Psoriasis Treatment Market Overview
     14.3. Middle East & Africa Market Value Share Analysis, by Product
     14.4. Middle East & Africa Market Forecast, by Product
           14.4.1. TNF Inhibitors
           14.4.2. Vitamin D Analogues or Combinations
           14.4.3. Interleukin Blockers
           14.4.4. Others
     14.5. Middle East & Africa Market Value Share Analysis, by Therapy
     14.6. Middle East & Africa Market Forecast, by Therapy
           14.6.1. Topical Therapeutic Drugs
           14.6.2. Systemic Therapeutic Drugs
           14.6.3. Combinations & Others 
     14.7. Middle East & Africa Psoriasis Treatment Market Value Share Analysis, by Distribution Channel
     14.8. Middle East & Africa Market Forecast, by Distribution Channel
           14.8.1. Hospital Pharmacy
           14.8.2. Retail Pharmacy
           14.8.3. Online Sales 
     14.9. Market Analysis, by Country
     14.10. Market Value Share Analysis, by Country
     14.11. Market Size (US$ Mn) Forecast, by Country, 2016–2024
           14.11.1. South Africa
           14.11.2. Saudi Arabia
           14.11.3. Rest of Middle East & Africa
     14.12. Market Attractiveness Analysis
           14.12.1. By Product
           14.12.2. By Therapy
           14.12.3. By Distribution Channel
           14.12.4. By Country
     14.13. Market Trends

15. Company Profiles
     15.1. Psoriasis Treatment Market Share Analysis, by Company (2015)
     15.2. Competition Matrix
     15.3. Company Profiles
           15.3.1. Amgen, Inc.
                    15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.1.2. Financial Overview
                    15.3.1.3. Product Portfolio
                    15.3.1.4. SWOT Analysis
                    15.3.1.5. Strategic Overview
           15.3.2. Eli Lilly & Company
                    15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.2.2. Financial Overview
                    15.3.2.3. Product Portfolio
                    15.3.2.4. SWOT Analysis
                    15.3.2.5. Strategic Overview
           15.3.3. Novartis AG
                    15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.3.2. Financial Overview
                    15.3.3.3. Product Portfolio
                    15.3.3.4. SWOT Analysis
                    15.3.3.5. Strategic Overview
           15.3.4. Merck & Co., Inc.
                    15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.4.2. Financial Overview
                    15.3.4.3. Product Portfolio
                    15.3.4.4. SWOT Analysis
                    15.3.4.5. Strategic Overview
           15.3.5. Johnson & Johnson
                    15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.5.2. Financial Overview
                    15.3.5.3. Product Portfolio
                    15.3.5.4. SWOT Analysis
                    15.3.5.5. Strategic Overview
           15.3.6. Pfizer, Inc.
                    15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.6.2. Financial Overview
                    15.3.6.3. Product Portfolio
                    15.3.6.4. SWOT Analysis
                    15.3.6.5. Strategic Overview
           15.3.7. AstraZeneca 
                    15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.7.2. Financial Overview
                    15.3.7.3. Product Portfolio
                    15.3.7.4. SWOT Analysis
                    15.3.7.5. Strategic Overview
           15.3.8. AbbVie, Inc.
                    15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.8.2. Financial Overview
                    15.3.8.3. Product Portfolio
                    15.3.8.4. SWOT Analysis
                    15.3.8.5. Strategic Overview
           15.3.9. LEO Pharma A/S
                    15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.9.2. Financial Overview
                    15.3.9.3. Product Portfolio
                    15.3.9.4. SWOT Analysis
                    15.3.9.5. Strategic Overview
           15.3.10. Biogen
                    15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    15.3.10.2. Financial Overview
                    15.3.10.3. Product Portfolio
                    15.3.10.4. SWOT Analysis
                    15.3.10.5. Strategic Overview

List of Figures

Figure 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 3: Global TNF Inhibitors Market Revenue (US$ Mn), 
Figure 4: Global Vitamin D Analogues or Combinations Market Revenue (US$ Mn), 2014–2024
Figure 5: Global Interleukin Blockers Market Revenue (US$ Mn), 2014–2024
Figure 6: Global Others Market Revenue (US$ Mn), 2014–2024
Figure 7: Psoriasis Treatment Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 8: Global Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 9: Global Topical Therapeutic Drugs Market Revenue (US$ Mn), 2014–2024
Figure 10: Global Systemic Therapeutic Drugs Market Revenue (US$ Mn), 2014–2024
Figure 11: Global Combinations & Others Market Revenue (US$ Mn), 2014–2024
Figure 12: Psoriasis Treatment Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 13: Global Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 14: Global Hospital Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 15: Global Retail Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Online Sales Market Revenue (US$ Mn), 2014–2024
Figure 17: Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 18: Global Psoriasis Treatment Market Value Share, by Region, 2016 and 2024
Figure 19: Psoriasis Treatment Market Attractiveness Analysis, by Region, 2016–2024
Figure 20: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 21: North America Market Attractiveness Analysis, 
Figure 22: North America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 23: North America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 24: North America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 25: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2016 and 2024
Figure 26: North America Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 27: North America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 28: North America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 29: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 30: Europe Market Attractiveness Analysis, 
Figure 31: Europe Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 32: Europe Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 33: Europe Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 34: Europe Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
Figure 35: Europe Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 36: Europe Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 37: Europe Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 38: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 39: Asia Pacific Market Attractiveness Analysis, 
Figure 40: Asia Pacific Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 41: Asia Pacific Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 42: Asia Pacific Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 43: Asia Pacific Psoriasis Treatment Market Value Share, by Country, 2016 and 2024
Figure 44: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 45: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 46: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 47: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 48: Latin America Market Attractiveness Analysis,
Figure 49: Latin America Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 50: Latin America Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 51: Latin America Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 52: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 53: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 54: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 55: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 56: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, 2016–2024
Figure 57: Middle East & Africa Market Attractiveness Analysis, 
Figure 58: Middle East & Africa Psoriasis Treatment Market Value Share, by Product Type, 2016 and 2024
Figure 59: Middle East & Africa Psoriasis Treatment Market Value Share, by Therapy, 2016 and 2024
Figure 60: Middle East & Africa Psoriasis Treatment Market Value Share, by Distribution Channel, 2016 and 2024
Figure 61: Middle East & Africa Market Value Share, by Country, 2016 and 2024
Figure 62: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Product
Figure 63: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Therapy
Figure 64: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Distribution Channel
Figure 65: Global Psoriasis Treatment Market Share Analysis, by Company (2015)

List of Tables

Table 1: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 3: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 4: Global Psoriasis Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 5: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 6: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 7: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 8: North America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 9: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 11: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 14: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 15: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Asia Pacific Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 18: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 19: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Latin America Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 22: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 23: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 24: Middle East & Africa Psoriasis Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024

Global Psoriasis Treatment Market - Overview

This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors expected to drive the growth of global Psoriasis Treatment market during the forecast period.

The Psoriasis Treatment market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on products, distribution channel, therapy type and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section.

Additionally, the section comprises Porter’s Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Psoriasis Treatment market.

Global Psoriasis Treatment Market - Segmentation

In this report, the market segments have been analyzed based on availability of approved products, cost-effectiveness, and preference for technological systems by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on product type, the market has been segmented into TNF Inhibitors, Vitamin D analogues or its combination, Interleukin Blockers and Others. Interleukin blockers segment is likely to be the most attractive segment in the near future due to its increasing use and its ability to act selectively by targeting the proteins. The segment is expected to grow at a highest CAGR rate during forecast period.

Based on Therapy type, the global Psoriasis Treatment market has been segmented into Topical Therapeutic Drugs, Systemic Therapeutic Drugs, Combinations of therapies & others. The market segments have been extensively analyzed based on increase in demand for the therapies, availability of the drug products, and cost of therapy and severity of the disease.

Different types of distribution channels are responsible for making the psoriasis treatment available in the market. The distribution channels are Hospital pharmacy, Retail pharmacy and the online sales. Under the distribution channel segment, hospital pharmacy plays a major role followed by retail pharmacy and online sales.

Geographically, the global Psoriasis Treatment market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, Japan, China, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, Saudi Arabia, and Rest of Middle East & Africa).

Companies Mentioned in the Report

The report also profiles major players in the global Psoriasis Treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Amgen Inc., Eli Lilly and Company, Novartis AG, Merck & Co., Inc., Johnson & Johnson, Pfizer, Inc., AstraZeneca, AbbVie Inc., LEO Pharma A/S and Biogen.

The Global Psoriasis Treatment Market has been segmented as given below:

Psoriasis Treatment Market, by Product

  • TNF Inhibitors
  • Vitamin D Analogues or Combinations
  • Interleukin Blockers
  • Others 

Psoriasis Treatment Market, by Therapy

  • Topical Therapeutic Drugs
  • Systemic Therapeutic Drugs
  • Combinations
  • Others

Psoriasis Treatment Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Others

Psoriasis Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top